NINGBO INNO PHARMCHEM CO.,LTD. Logo
Home Contact Us
  1. Home
  2. News Tag: Preclinical Safety

News Articles Tagged: Preclinical Safety

Preclinical Safety Profile of Novel Gefitinib-Triazole Derivatives for Lung Cancer

NINGBO INNO PHARMCHEM CO.,LTD. presents findings on the preclinical safety of new gefitinib-1,2,3-triazole derivatives, highlighting their low toxicity and potential for clinical use.

Gemcitabine Hydrochloride: A Deep Dive into its Pharmacological Properties

NINGBO INNO PHARMCHEM CO.,LTD. provides a scientific overview of Gemcitabine Hydrochloride's pharmacological properties, including its metabolism, pharmacokinetics, and preclinical safety data.

Exploring the Safety and Efficacy of Novel Obesity Peptides in Animal Models: A Preclinical Review

Examine the preclinical findings on novel obesity peptides, focusing on their safety profile and effectiveness in various animal models, providing insights into their potential for human application.

The Safety and Efficacy Profile of BAM15: A Mitochondrial Uncoupler for Therapeutic Use

Examine the safety and efficacy of BAM15, a mitochondrial uncoupler, detailing its preclinical findings on tolerability, bioavailability, and therapeutic potential.

Start Your Journey to Higher Quality

Reach out to our technical specialists today for customized solutions, samples, and a detailed quote. We are excited to build a brilliant future together.

Send an Inquiry by Email

NINGBO INNO PHARMCHEM CO.,LTD.

Add: 163 Ruiqing Road,Ningbo Zhejiang 315000 China | Tel:+86 574 87319282 / 87314919

© 2025 All Rights Reserved.